Sympathetic stimulation can compensate for hypocalcaemia-induced bradycardia in human and rabbit sinoatrial node

Moritz Linder1, Tomas Stary1, Gergő Bitay2

  • 1Institute of Biomedical Engineering, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

The Journal of Physiology
|February 27, 2025
PubMed

Insights

Hypocalcaemia in haemodialysis patients can decrease heart rate, but increased sympathetic stimulation can compensate. This study models sinoatrial node cell function to understand these effects and potential risks of sudden cardiac death.

Area of Science:

  • Cardiovascular Physiology
  • Computational Biology
  • Electrophysiology

Background:

  • Sinoatrial node cells (SANCs) regulate heart rhythm through spontaneous depolarization.
  • Electrolyte imbalances and autonomic nervous system (ANS) activity significantly impact SANC function.
  • Haemodialysis (HD) patients often experience electrolyte variations affecting cardiac function.

Purpose of the Study:

  • To investigate the combined effects of hypocalcaemia and sympathetic stimulation on SANC beating rate (BR).
  • To model the β-adrenergic receptor (β-AR) signaling cascade within existing SANC models.
  • To understand the implications for cardiovascular diseases, particularly sudden cardiac death (SCD) in HD patients.

Main Methods:

  • Extended rabbit (Severi et al.) and human (Fabbri et al.) SANC models by incorporating the β-AR signaling cascade (Behar et al.).
  • Conducted computational simulations across a range of extracellular calcium ([Ca²⁺]₀) and isoprenaline (ISO) concentrations.
  • Validated model responses against experimental data from Langendorff-perfused rabbit hearts and literature.

Main Results:

  • Decreased [Ca²⁺]₀ required an exponential increase in [ISO] to restore basal BR.
  • Specific [ISO] levels needed to compensate for hypocalcaemia varied between rabbit and human models.
  • Reduced [Ca²⁺]₀ combined with loss of sympathetic tone led to rapid loss of automaticity.
  • Sympathetic stimulation can compensate for hypocalcaemia-induced bradycardia.

Conclusions:

  • The integrated models provide insights into the compensatory mechanisms of hypocalcaemia and sympathetic tone on SANC function.
  • Interspecies differences in model sensitivity highlight variations in response to hypocalcaemia and sympathetic tone.
  • These findings contribute to understanding the pathomechanisms of cardiac arrhythmias and SCD in chronic kidney disease patients.

Related Concept Videos

Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
4.1K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.5K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
1.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
699
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
495
Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
529